Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Biogen buys UK-based neuropathic pain drug developer for up to $675M

 

Biogen buys UK-based neuropathic pain drug developer for up to $675M

2015-01-12 06:43:14| Biotech - Topix.net

Biogen Idec is getting into the neuropathic pain treatment field with the acquisition of a U.K. drug developer for up to $675 million. The Cambridge biotech firm , known best for its drugs for multiple sclerosis, announced the acquisition of Convergence Pharmaceuticals on the first weekend of the J.P. Morgan Healthcare conference in San Francisco.

Tags: drug pain developer buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

26.06 Disruption as airline pilots begin industrial action 26.06 Atlantic Tropical Weather Outlook 26.06 Eastern North Pacific Tropical Weather Outlook 26.06 Now is not the time for African swine fever fatigue 26.06 Ex-BHS director must pay 50m over firm's collapse 26.06 WEG Mexico Obtains Quality Certificate from QUALICOAT 26.06 Pork producers lead coalition against sprinkler mandate 26.06 Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield More »